Related Experiment Video
Updated: Jul 13, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study
Hoyun Kim1, Do-Yoon Kang1, Jung-Min Ahn1
1Heart Institute, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Insights
For patients with multivessel coronary artery disease, coronary artery bypass grafting (CABG) shows better outcomes than percutaneous coronary intervention (PCI) in diabetics. Mortality rates were similar between CABG and PCI regardless of diabetes status.
Area of Science:
- Cardiology
- Interventional Cardiology
- Diabetes Mellitus Research
Background:
- Diabetes mellitus is linked to more complex coronary artery disease.
- Coronary artery bypass grafting (CABG) is often preferred over percutaneous coronary intervention (PCI) for diabetics with multivessel coronary artery disease (MVD).
Purpose of the Study:
- To evaluate the prognostic impact of revascularization strategies (PCI vs. CABG) based on diabetes status.
- To analyze outcomes from the BEST trial, comparing PCI with everolimus-eluting stents to CABG in MVD patients.
Main Methods:
- 880 patients with MVD were randomized to PCI or CABG.
- Patients were stratified into diabetic (n=363) and nondiabetic (n=517) groups.
- The primary endpoint was a composite of death, myocardial infarction, or target vessel revascularization over an 11.8-year median follow-up.
Main Results:
- Diabetic patients had a significantly higher primary endpoint rate with PCI versus CABG (43% vs. 32%).
- No significant difference in the primary endpoint was observed between PCI and CABG in nondiabetic patients (29% vs. 29%).
- Repeat revascularization rates were higher with PCI compared to CABG, irrespective of diabetes status.
Conclusions:
- CABG demonstrated superior clinical outcomes compared to PCI in diabetic patients with MVD.
- Mortality rates were comparable between PCI and CABG across both diabetic and nondiabetic groups during extended follow-up.
Background:
Diabetes mellitus is associated with more complex coronary artery diseases. Coronary artery bypass grafting (CABG) is a preferred revascularization strategy over percutaneous coronary intervention (PCI) in diabetics with multivessel coronary artery disease (MVD).
Objectives:
This study sought to examine the different prognostic effects of revascularization strategies according to the diabetes status from the randomized BEST (Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) trial.
Methods:
Patients (n = 880) with MVD were randomly assigned to undergo PCI with an everolimus-eluting stent vs CABG stratified by diabetics (n = 363) and nondiabetics (n = 517). The primary endpoint was the composite of death, myocardial infarction, or target vessel revascularization during a median follow-up of 11.8 years (IQR: 10.6-12.5 years).
Results:
In diabetics, the primary endpoint rate was significantly higher in the PCI group than in the CABG group (43% and 32%; HR: 1.53; 95% CI: 1.12-2.08; P = 0.008). However, in nondiabetics, no significant difference was found between the groups (PCI group, 29%; CABG group, 29%; HR: 0.97; 95% CI: 0.67-1.39; P = 0.86; Pinteraction= 0.009). Irrespective of the presence of diabetes, no significant between-group differences were found in the rate of a safety composite of death, myocardial infarction, or stroke and mortality rate. However, the rate of any repeat revascularization was significantly higher in the PCI group than in the CABG group.
Conclusions:
In diabetics with MVD, CABG was associated with better clinical outcomes than PCI. However, the mortality rate was similar between PCI and CABG irrespective of diabetes status during an extended follow-up. (Ten-Year Outcomes of Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease [BEST Extended], NCT05125367; Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease [BEST], NCT00997828).
More Related Videos
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Mitral Stenosis III: Medical Management
Peripheral Artery Disease V: Postoperative Nursing Management
Atherosclerosis III: Management